RxDoctor Payments Data

Yolanda Jones, MD

Hospitalist · Phoenix, AZNPI 1154595254

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.1% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Coloplast accounts for 60.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $333 and has fallen 82.5% since, to $58 in 2025. Among hospitalist clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,017in general payments, 2019–2025

Across 31 payments — averaging $32.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$616
  • Lilly USA, LLC$122
  • Novo Nordisk$108
  • Roche Diagnostics Corporation$35
  • Avadel CNS Pharmaceuticals, LLC$33
  • Pfizer$32
  • plus $69 from 4 others

What the payments were for

  • Food & beverage$98797%
  • Education$293%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,017 in reported general payments places this provider in the 90th percentile of 578 hospitalist providers in Arizona.

See all hospitalist providers in Arizona

Medicare billing

Part B allowed, 2024
$8,407
Medicare patients
40
Services billed
82

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol28$2,709
ProgesteroneProgesterone, Micronized22$574

Paid to pharmacies, not to this prescriber.

Other hospitalist in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →